Hualan Biological EngineeringInc (002007) — Cash Flow Reinvestment Rate
Hualan Biological EngineeringInc (002007) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting CN¥36.14 Million (capex CN¥36.14 Million ) from operating cash flow of CN¥319.46 Million. Explore 002007 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hualan Biological EngineeringInc Cash Flow Reinvestment Rate (2003–2024)
Historical reinvestment intensity for Hualan Biological EngineeringInc across 22 annual periods. Also explore Hualan Biological EngineeringInc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hualan Biological EngineeringInc (2003–2024)
Year-by-year capital reinvestment analysis for Hualan Biological EngineeringInc. For live market cap and broader valuation context, see 002007 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | CN¥599.21 Million | CN¥1.06 Billion | CN¥255.79 Million | ▼ -56.5% |
| 2023 | 1.30x | CN¥1.75 Billion | CN¥1.35 Billion | CN¥753.41 Million | ▼ -51.5% |
| 2022 | 2.68x | CN¥2.57 Billion | CN¥957.31 Million | CN¥393.95 Million | ▲ +103.8% |
| 2021 | 1.32x | CN¥1.89 Billion | CN¥1.43 Billion | CN¥811.35 Million | ▲ +106.5% |
| 2020 | 0.64x | CN¥845.31 Million | CN¥1.33 Billion | CN¥621.44 Million | ▲ +2.9% |
| 2019 | 0.62x | CN¥845.09 Million | CN¥1.36 Billion | CN¥272.95 Million | ▼ -14.4% |
| 2018 | 0.72x | CN¥936.97 Million | CN¥1.29 Billion | CN¥183.26 Million | ▲ +3.6% |
| 2017 | 0.70x | CN¥124.12 Million | CN¥177.42 Million | CN¥108.54 Million | ▼ -3.8% |
| 2016 | 0.73x | CN¥239.94 Million | CN¥329.94 Million | CN¥220.66 Million | ▼ -29.9% |
| 2015 | 1.04x | CN¥569.20 Million | CN¥548.62 Million | CN¥229.34 Million | ▲ +270.5% |
| 2014 | 0.28x | CN¥139.21 Million | CN¥497.15 Million | CN¥139.21 Million | ▼ -42.6% |
| 2013 | 0.49x | CN¥249.21 Million | CN¥510.70 Million | CN¥249.21 Million | ▲ +64.0% |
| 2012 | 0.30x | CN¥147.15 Million | CN¥494.69 Million | CN¥147.15 Million | ▼ -30.4% |
| 2011 | 0.43x | CN¥143.59 Million | CN¥335.93 Million | CN¥143.59 Million | ▲ +74.1% |
| 2010 | 0.25x | CN¥149.67 Million | CN¥609.53 Million | CN¥149.67 Million | ▼ -8.1% |
| 2009 | 0.27x | CN¥162.43 Million | CN¥607.73 Million | CN¥162.43 Million | ▼ -66.1% |
| 2008 | 0.79x | CN¥126.90 Million | CN¥161.18 Million | CN¥126.90 Million | ▼ -34.1% |
| 2007 | 1.19x | CN¥213.92 Million | CN¥179.02 Million | CN¥213.92 Million | ▼ -27.7% |
| 2006 | 1.65x | CN¥217.30 Million | CN¥131.43 Million | CN¥217.30 Million | ▲ +177.2% |
| 2005 | 0.60x | CN¥58.59 Million | CN¥98.24 Million | CN¥58.59 Million | ▼ -41.8% |
| 2004 | 1.02x | CN¥22.00 Million | CN¥21.48 Million | CN¥22.00 Million | ▼ -89.6% |
| 2003 | 9.81x | CN¥32.82 Million | CN¥3.35 Million | CN¥32.82 Million | — |